Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
0 hedge funds and large institutions have $0 invested in Bio Green Med Solution Inc Preferred Stock in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
1.14% less ownership
Funds ownership: 1.14% → 0% (-1.1%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $23K → $0 (-$23K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$23K | -3,891 | Closed |
|
BGMSP Hedge Fund Activity: Q2 2020 in Review
0 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q2 2020, worth a combined $0 — down 100% from $23K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMSP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $23K sold.
- 0 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q2 2020, down from 1 in Q1 2020.
- Funds reported $0 of Bio Green Med Solution Inc Preferred Stock stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q2 2020 was UBS Group, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2020.